These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predicting efficacy of electroconvulsive therapy in major depressive disorder. Tsuchiyama K; Nagayama H; Yamada K; Isogawa K; Katsuragi S; Kiyota A Psychiatry Clin Neurosci; 2005 Oct; 59(5):546-50. PubMed ID: 16194256 [TBL] [Abstract][Full Text] [Related]
4. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode. Tafalla M; Sanchez-Moreno J; Diez T; Vieta E J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169 [TBL] [Abstract][Full Text] [Related]
5. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S; J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184 [TBL] [Abstract][Full Text] [Related]
6. Classifying mood disorders by age-at-onset instead of polarity. Benazzi F Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784 [TBL] [Abstract][Full Text] [Related]
7. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Vuorilehto MS; Melartin TK; Isometsä ET Psychol Med; 2009 Oct; 39(10):1697-707. PubMed ID: 19250580 [TBL] [Abstract][Full Text] [Related]
8. Borderline personality disorder characteristics in young adults with recurrent mood disorders: a comparison of bipolar and unipolar depression. Smith DJ; Muir WJ; Blackwood DH J Affect Disord; 2005 Jul; 87(1):17-23. PubMed ID: 15967232 [TBL] [Abstract][Full Text] [Related]
9. Recurrence of major depressive disorder is predicted by inhibited startle magnitude while recovered. O'Brien-Simpson L; Di Parsia P; Simmons JG; Allen NB J Affect Disord; 2009 Jan; 112(1-3):243-9. PubMed ID: 18495249 [TBL] [Abstract][Full Text] [Related]
10. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Rabe-Jabłońska J; Poprawska I Med Sci Monit; 2000; 6(3):539-47. PubMed ID: 11208367 [TBL] [Abstract][Full Text] [Related]
11. The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptoms. Leskelä U; Rytsälä H; Komulainen E; Melartin T; Sokero P; Lestelä-Mielonen P; Isometsä E Psychol Med; 2006 Jun; 36(6):779-88. PubMed ID: 16566849 [TBL] [Abstract][Full Text] [Related]
13. The effect of depression on quality of life of patients with type II diabetes mellitus. Eren I; Erdi O; Sahin M Depress Anxiety; 2008; 25(2):98-106. PubMed ID: 17311266 [TBL] [Abstract][Full Text] [Related]
14. Power laws in covariability of anxiety and depression among newly diagnosed patients with major depressive episode, panic disorder and controls. Katerndahl DA J Eval Clin Pract; 2009 Jun; 15(3):565-70. PubMed ID: 19522912 [TBL] [Abstract][Full Text] [Related]
15. Clinical and demographic factors associated with DSM-IV melancholic depression. Khan AY; Carrithers J; Preskorn SH; Lear R; Wisniewski SR; John Rush A; Stegman D; Kelley C; Kreiner K; Nierenberg AA; Fava M Ann Clin Psychiatry; 2006; 18(2):91-8. PubMed ID: 16754414 [TBL] [Abstract][Full Text] [Related]
16. How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity? Benazzi F; Akiskal HS J Affect Disord; 2008 Apr; 107(1-3):77-88. PubMed ID: 17854907 [TBL] [Abstract][Full Text] [Related]
17. A tetrachoric factor analysis validation of mixed depression. Benazzi F Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):186-92. PubMed ID: 17804137 [TBL] [Abstract][Full Text] [Related]
18. Influence of episode duration of major depressive disorder on response to electroconvulsive therapy. Pluijms EM; Birkenhäger TK; Mulder PG; van den Broek WW J Affect Disord; 2006 Feb; 90(2-3):233-7. PubMed ID: 16376432 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831 [TBL] [Abstract][Full Text] [Related]
20. The impact of migraine on patients with major depressive disorder. Hung CI; Liu CY; Juang YY; Wang SJ Headache; 2006 Mar; 46(3):469-77. PubMed ID: 16618265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]